Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: A report from the SPORTIF III and V trials-Reference-Cited by-同舟云学术

Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: A report from the SPORTIF III and V trials

Published:2007-05-11 Issue:6-7 Volume:9 Page:730-739
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Cleland John G.F.¹,Shelton Rhiddian¹,Nikitin Nikolay¹,Ford Sarah¹,Frison Lars²,Grind Margaretha²

Affiliation:

1. Department of Cardiology; Kingston-upon-Hull UK

2. AstraZeneca; Mölndal Sweden

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Systematic review of the management of atrial fibrillation in patients with heart failure;Khand;Eur Heart J,2000

2. Defining diastolic heart failure: a call for standardized diagnostic criteria;Vasan;Circulation,2000

3. How to diagnose diastolic heart failure;European Study Group on Diastolic Heart Failure;Eur Heart J,1998

4. Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart Failure-Assessment of Reduction in Mortality and Morbidity (CHARM) programme;McMurray;Eur J Heart Fail,2003

5. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study;Curtis;Am Heart J,2005

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loop diuretic therapy with or without heart failure: impact on prognosis;European Heart Journal;2024-06-07

2. Diagnosis and initial management of heart failure;Considerations in Medicine;2024-06

3. Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications;Clinical Research in Cardiology;2022-11-17

4. Predicting mortality after hospitalisation for COPD using electronic health records;Pharmacological Research;2022-05

5. Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology;European Heart Journal;2021-12-07